Wuxi Capital logo

Wuxi Capital

Asia, Jiangsu, China, Wuxi Shi

Description

Wuxi Capital is a financial investment platform.

Investor Profile

Wuxi Capital has made 10 investments, with 7 in the past 12 months and 30% as lead.

Stage Focus

  • Series B (40%)
  • Seed (30%)
  • Series A (20%)
  • Series E (10%)

Country Focus

  • China (90%)
  • Hong Kong (10%)

Industry Focus

  • Health Care
  • Medical
  • Biotechnology
  • Artificial Intelligence (Ai)
  • Pharmaceutical
  • Medical Device
  • Biopharma
  • Advanced Materials
  • Product Research
  • Semiconductor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wuxi Capital frequently co-invest with?

Med-Fine Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Ennovation Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 1
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
Ascendin Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
Golden Capital Partners
North America, California, United States, Santa Monica
Co-Investments: 1
Volcanics Venture
Asia, Shanghai, China, Changning
Co-Investments: 1
Co-Investments: 1
Delian Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Emerging Technology Partners
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Wuxi Capital?

RoboCT

Yuhang, Zhejiang, China

RoboCT is a developer of exoskeleton robot technology that helps patients with lower-body motor dysfunction learn to walk.

Artificial Intelligence (AI)Assistive TechnologyMedical DeviceRehabilitationRoboticsSoftware
Series BMar 27, 2025
Amount Raised: $13,772,208
Insilico Medicine

Hong Kong, Hong Kong Island, Hong Kong

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical
Series EMar 13, 2025
Amount Raised: $110,000,000
Weimai Medical

Wuxi Shi, Jiangsu, China

Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.

MedicalMedical Device
Series BFeb 17, 2025
Cyberpunk Technology

Wuxi Shi, Jiangsu, China

Cyberpunk is the developer and manufacturer of digital orthopedics solutions for foot and ankle and deformity correction

Health CareMedical
Series AJan 6, 2025
Tushen Zhihe

Minhang, Shanghai, China

Tushen Zhihe is an artificial intelligence protein design service provider.

Artificial Intelligence (AI)BiotechnologyPharmaceutical
SeedDec 31, 2024
Zhongke Yunmo

Wuxi Shi, Jiangsu, China

Zhongke Yunmo is a tech firm focused on developing commercial applications of digital twin and metaverse technologies.

AppsInternet of ThingsMetaverse
Series AOct 28, 2024
Yixi Technology

Minhang, Shanghai, China

Yixi Technology is a high-temperature superconducting magnet company.

Advanced MaterialsProduct ResearchSemiconductor
SeedOct 25, 2024
Amount Raised: $14,042,774
Hope Medicine

Nanjing, Jiangsu, China

Hope Medicine is a science-driven clinical stage biopharmaceutical company

Health CareMedical
Series BFeb 7, 2024
Amount Raised: $28,117,531
CorrGene

Nanjing, Jiangsu, China

CorrGene is a researcher and developer of rare disease cell therapy.

BiotechnologyHealth CareMedical
SeedFeb 28, 2022
Amount Raised: $15,700,000
Polaris Biology

Shanghai, Shanghai, China

Polaris Biology is a medical technology company specializing in the development and clinical application.

BiopharmaBiotechnologyHealth CareMedical
Series BJun 24, 2020
Amount Raised: $9,889,520